vers la météo de la validation par utilisateur
+----------------------------------------------COMP:V-N(with)----------------------------------------------+ +----------------------------------COMP:V-N(from)---------------------------------+ | +-----------------------OBJ:V-N-----------------------+ | | | +----------------MOD_ATT:N-ADJ----------------+ | | | | +-------------MOD_ATT:N-N-------------+ | | | | | +---------MOD_ATT:N-N--------+ | | | | | | +----MOD_ATT:N-N---+ | | | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | | +MOD_AT+SUBJ:+ | | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) COMP:V-N(from) (__SP__,__SP__) COMP:V-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,Bis) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) MOD_ATT:N-ADJ (carcinoma,prostatic)
+----------------------------------------------COMP:V-N(with)----------------------------------------------+ +----------------------------------COMP:V-N(from)---------------------------------+ | +-----------------------OBJ:V-N-----------------------+ | | | +----------------MOD_ATT:N-ADJ----------------+ | | | | +-------------MOD_ATT:N-N-------------+ | | | | | +---------MOD_ATT:N-N--------+ | | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | | +MOD_AT+SUBJ:+ | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) COMP:V-N(from) (__SP__,__SP__) COMP:V-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) MOD_ATT:N-ADJ (carcinoma,prostatic)
+----------------------------------COMP:V-N(from)---------------------------------+ +-----------------------OBJ:V-N-----------------------+ | | +----------------MOD_ATT:N-ADJ----------------+ | | | +-------------MOD_ATT:N-N-------------+ | | | | +---------MOD_ATT:N-N--------+ | | | | | +----MOD_ATT:N-N---+ | | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ +-----COMP:N-N(with)-----+ +MOD_AT+SUBJ:+ | | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) COMP:V-N(from) (__SP__,__SP__) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,Bis) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) COMP:N-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (carcinoma,prostatic)
+----------------------------------------------COMP:V-N(with)----------------------------------------------+ +-----------------------OBJ:V-N-----------------------+ | | +----------------MOD_ATT:N-ADJ----------------+ | | | +-------------MOD_ATT:N-N-------------+ | | | | +---------MOD_ATT:N-N--------+ | | | | | +----MOD_ATT:N-N---+ | | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | +MOD_AT+SUBJ:+ | | | | | +MOD_ATT:+ +MOD_+COMP:N-N(fr+ +MOD_ATT:N+ | | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) COMP:V-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,Bis) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) COMP:N-N(from) (line,__SP__) MOD_ATT:N-ADJ (carcinoma,prostatic)
+----------------------------------------------COMP:V-N(with)----------------------------------------------+ +-----------------------OBJ:V-N-----------------------+ | | +----------------MOD_ATT:N-ADJ----------------+ | | | +-------------MOD_ATT:N-N-------------+ | | | | +---------MOD_ATT:N-N--------+ | | | | | +----MOD_ATT:N-N---+-------COMP:N-N(from)------+ | | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | | +MOD_AT+SUBJ:+ | | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) COMP:V-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,Bis) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) COMP:N-N(from) (apoptosis,__SP__) MOD_ATT:N-N (line,cell) MOD_ATT:N-ADJ (carcinoma,prostatic)
+----------------------------------COMP:V-N(from)---------------------------------+ +-----------------------OBJ:V-N-----------------------+ | | +----------------MOD_ATT:N-ADJ----------------+ | | | +-------------MOD_ATT:N-N-------------+ | | | | +---------MOD_ATT:N-N--------+ | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ +-----COMP:N-N(with)-----+ +MOD_AT+SUBJ:+ | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) COMP:V-N(from) (__SP__,__SP__) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) COMP:N-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (carcinoma,prostatic)
+----------------------------------------------COMP:V-N(with)----------------------------------------------+ +-----------------------OBJ:V-N-----------------------+ | | +----------------MOD_ATT:N-ADJ----------------+ | | | +-------------MOD_ATT:N-N-------------+ | | | | +---------MOD_ATT:N-N--------+ | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | +MOD_AT+SUBJ:+ | | | | +MOD_ATT:+ +MOD_+COMP:N-N(fr+ +MOD_ATT:N+ | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) COMP:V-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) COMP:N-N(from) (line,__SP__) MOD_ATT:N-ADJ (carcinoma,prostatic)
+----------------------------------------------COMP:V-N(with)----------------------------------------------+ +-----------------------OBJ:V-N-----------------------+ | | +----------------MOD_ATT:N-ADJ----------------+ | | | +-------------MOD_ATT:N-N-------------+ | | | | +---------MOD_ATT:N-N--------+-------COMP:N-N(from)------+ | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | | +MOD_AT+SUBJ:+ | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) COMP:V-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) COMP:N-N(from) (apoptosis,__SP__) MOD_ATT:N-N (line,cell) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+ | | | +---------MOD_ATT:N-N--------+ | | | | +----MOD_ATT:N-N---+ | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ +-----COMP:N-N(with)-----+ +MOD_AT+SUBJ:+ | | | | | +MOD_ATT:+ +MOD_+COMP:N-N(fr+ +MOD_ATT:N+ | | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,Bis) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) COMP:N-N(from) (line,__SP__) COMP:N-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+ | | | +---------MOD_ATT:N-N--------+ | | | | +----MOD_ATT:N-N---+ | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+-----------COMP:N-N(with)-----------+ +MOD_AT+SUBJ:+ | | | | | +MOD_ATT:+ +MOD_+COMP:N-N(fr+ +MOD_ATT:N+ | | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,Bis) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) COMP:N-N(from) (line,__SP__) COMP:N-N(with) (line,carcinoma) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+ | | | +---------MOD_ATT:N-N--------+ | | | | +----MOD_ATT:N-N---+-------COMP:N-N(from)------+ | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ +-----COMP:N-N(with)-----+ +MOD_AT+SUBJ:+ | | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,Bis) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) COMP:N-N(from) (apoptosis,__SP__) MOD_ATT:N-N (line,cell) COMP:N-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+ | | | +---------MOD_ATT:N-N--------+ | | | | +----MOD_ATT:N-N---+-------------------COMP:N-N(with)-------------------+ | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | +MOD_AT+SUBJ:+ | | | | | +MOD_ATT:+ +MOD_+COMP:N-N(fr+ +MOD_ATT:N+ | | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,Bis) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) COMP:N-N(with) (apoptosis,carcinoma) MOD_ATT:N-N (line,cell) COMP:N-N(from) (line,__SP__) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+ | | | +---------MOD_ATT:N-N--------+-------------------COMP:N-N(with)-------------------+ | | | | +----MOD_ATT:N-N---+-------COMP:N-N(from)------+ | | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | | +MOD_AT+SUBJ:+ | | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,Bis) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) COMP:N-N(from) (apoptosis,__SP__) COMP:N-N(with) (apoptosis,carcinoma) MOD_ATT:N-N (line,cell) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+ | | | +---------MOD_ATT:N-N--------+ | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ +-----COMP:N-N(with)-----+ +MOD_AT+SUBJ:+ | | | | +MOD_ATT:+ +MOD_+COMP:N-N(fr+ +MOD_ATT:N+ | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) COMP:N-N(from) (line,__SP__) COMP:N-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+ | | | +---------MOD_ATT:N-N--------+ | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+-----------COMP:N-N(with)-----------+ +MOD_AT+SUBJ:+ | | | | +MOD_ATT:+ +MOD_+COMP:N-N(fr+ +MOD_ATT:N+ | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) MOD_ATT:N-N (line,cell) COMP:N-N(from) (line,__SP__) COMP:N-N(with) (line,carcinoma) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+ | | | +---------MOD_ATT:N-N--------+-------COMP:N-N(from)------+ | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ +-----COMP:N-N(with)-----+ +MOD_AT+SUBJ:+ | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) COMP:N-N(from) (apoptosis,__SP__) MOD_ATT:N-N (line,cell) COMP:N-N(with) (__SP__,carcinoma) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+ | | | +---------MOD_ATT:N-N--------+-------------------COMP:N-N(with)-------------------+ | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | +MOD_AT+SUBJ:+ | | | | +MOD_ATT:+ +MOD_+COMP:N-N(fr+ +MOD_ATT:N+ | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) COMP:N-N(with) (apoptosis,carcinoma) MOD_ATT:N-N (line,cell) COMP:N-N(from) (line,__SP__) MOD_ATT:N-ADJ (carcinoma,prostatic)
+-----------------------OBJ:V-N-----------------------+ | +----------------MOD_ATT:N-ADJ----------------+ | | +-------------MOD_ATT:N-N-------------+-------------------COMP:N-N(with)-------------------+ | | | +---------MOD_ATT:N-N--------+-------COMP:N-N(from)------+ | | | | | +--MOD_ATT:N-N-+--COMP:N-N(of)-+ | | +MOD_AT+SUBJ:+ | | | | +MOD_ATT:+ +MOD_+ | +MOD_ATT:N+ | | | | | | | | | | | | | | Agonist anti __SP__ __NODE__ protein antibody and Bis IX increase apoptosis of cell lines from __SP__ with a prostatic carcinoma . MOD_ATT:N-N (anti,agonist) SUBJ:V-N (__SP__,anti) OBJ:V-N (__SP__,apoptosis) MOD_ATT:N-ADJ (apoptosis,__NODE__) MOD_ATT:N-N (apoptosis,protein) MOD_ATT:N-N (apoptosis,antibody) MOD_ATT:N-N (apoptosis,IX) MOD_ATT:N-N (apoptosis,increase) COMP:N-N(of) (apoptosis,line) COMP:N-N(from) (apoptosis,__SP__) COMP:N-N(with) (apoptosis,carcinoma) MOD_ATT:N-N (line,cell) MOD_ATT:N-ADJ (carcinoma,prostatic)